SI
SI
discoversearch

Biotech / Medical : MGNX -- MacroGenics
MGNX 23.300.0%Feb 16 8:10 PM ESTNews

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (56)9/1/2017 7:17:31 PM
From: tuck  Read Replies (1) of 89
 
MGD006 may just follow CD3xCD19 path. :-(
But I don't see anyone with much of lead against CD123. And even the other CD3 bispecific I'm aware have different targets for the other arms of their bispecifics. So I don't feel they are as far behind in development with that one.


MGD013, dosing to start soon . . . any guesses (a ballpark guess will do) on when we'd see the first data from that P1?


TIA & Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.